Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
89,17 USD | +1,92 % | +2,90 % | +28,93 % |
13/09 | CRH PLC : Obtiene una recomendación de compra de Deutsche Bank Securities | ZM |
13/09 | Deutsche Bank rebaja AstraZeneca a 'vender | AN |
Añadir a una lista 0 seleccionado | Ventas netas ($) (Y-1) | Margen neto (Y-1) | Margen Operativo (Y-1) | ROE (Y-1) | ROA (Y-1) | Apalancamiento (Dette/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
35,93 mil M | +9.09% | +11.98% | +15.67% | +6.85% | 0.88x | ||
8478,35 M | +9.88% | +13.85% | +12.32% | +7.35% | 0.31x | ||
6777,2 M | +17.25% | +23.55% | +15.37% | +7.76% | 1.44x | ||
7781,9 M | +11.99% | +18.34% | +12.99% | +6.50% | 1.46x | ||
3090,51 M | +3.66% | +4.26% | +3.05% | - | 2.69x | ||
23,59 mil M | +9.11% | +14.27% | +11.42% | +5.61% | 1.24x | ||
2142,58 M | +13.03% | +13.49% | +7.13% | - | -2.44x | ||
17,42 mil M | +1.05% | +12.14% | +1.63% | +0.66% | 2.05x | ||
2442,74 M | +11.70% | +12.72% | +8.79% | +6.08% | 3.31x | ||
2830,3 M | +6.46% | +10.47% | +15.94% | - | - | ||
4705,21 M | +7.92% | +11.71% | +13.10% | - | 1.5x | ||
804 M | +33.45% | +60.07% | +14.00% | +8.68% | 0.82x | ||
6208,58 M | +4.88% | +6.37% | +8.20% | +4.56% | 2.57x | ||
614 M | +36.89% | +44.05% | +32.84% | - | -0.11x | ||
29,74 mil M | +1.84% | +6.01% | +3.14% | +0.79% | 4.97x | ||
3978,39 M | +4.61% | +11.45% | - | - | 2.4x | ||
1974,33 M | +7.10% | +10.33% | +9.81% | - | 0.7x | ||
Promedio | 9323,87 M | +11,17 % | +16,77 % | +11,59 % | +5,48 % | 1,49x | |
Media ponderada por Capi. | 14,77 mil M | +10,47 % | +14,77 % | +12,08 % | +6,55 % | 1,06x |
- Bolsa de valores
- Acciones
- Acción CRH
- Sector CRH plc
- Comparaciones Financieras
MarketScreener is also available in this country: United States.
Switch edition